Published in J Cell Mol Med on July 28, 2009
Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells. Free Radic Biol Med (2014) 0.87
Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle. Biochim Biophys Acta (2013) 0.86
Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients. J Exp Clin Cancer Res (2012) 0.85
Costamere remodeling with muscle loading and unloading in healthy young men. J Anat (2013) 0.83
Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways. Exp Gerontol (2015) 0.78
miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy. Neural Regen Res (2016) 0.75
Agonist muscle adaptation accompanied by antagonist muscle atrophy in the hindlimb of mice following stretch-shortening contraction training. BMC Musculoskelet Disord (2017) 0.75
Stochastic effects in adaptive reconstruction of body damage: implied the creativity of natural selection. J Cell Mol Med (2015) 0.75
The Role of Exercise and TFAM in Preventing Skeletal Muscle Atrophy. J Cell Physiol (2016) 0.75
A Rat Immobilization Model Based on Cage Volume Reduction: A Physiological Model for Bed Rest? Front Physiol (2017) 0.75
Cell death: critical control points. Cell (2004) 22.56
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell (1993) 10.36
The calpain system. Physiol Rev (2003) 9.95
FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab (2007) 8.90
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab (2007) 8.05
Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med (2004) 7.80
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet (1997) 7.15
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J (2004) 7.02
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A (2001) 6.76
Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A (1997) 6.72
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol (2001) 6.71
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Endonuclease G is an apoptotic DNase when released from mitochondria. Nature (2001) 6.20
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev (2003) 5.91
Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A (2001) 5.80
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28
The logic of TGFbeta signaling. FEBS Lett (2006) 5.26
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (2000) 5.20
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Functional improvement of dystrophic muscle by myostatin blockade. Nature (2002) 5.10
Does this have a familiar RING? Trends Biochem Sci (1996) 4.80
Induction of cachexia in mice by systemically administered myostatin. Science (2002) 4.39
The many forks in FOXO's road. Sci STKE (2003) 4.23
The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol (2004) 3.92
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med (1996) 3.83
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr (1999) 3.45
The somatomedin hypothesis: 2001. Endocr Rev (2001) 3.16
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest (2004) 3.09
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem (2002) 3.01
Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest (2004) 2.98
Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr (2000) 2.93
Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet (1999) 2.90
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab (2007) 2.84
A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab (2006) 2.80
An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol (1997) 2.77
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem (2004) 2.72
Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol (2004) 2.58
Oxidative stress and disuse muscle atrophy. J Appl Physiol (1985) (2007) 2.53
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci U S A (2002) 2.53
Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. J Nutr (2000) 2.46
Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol (2005) 2.38
Gene expression profile of aging in human muscle. Physiol Genomics (2003) 2.36
TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev (2001) 2.35
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A (2004) 2.34
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem (2004) 2.32
Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. Am J Physiol (1996) 2.26
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care (2001) 2.18
Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem (1990) 2.14
Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest (2006) 2.13
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol (2006) 2.13
MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol (2005) 2.13
Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J (1995) 2.11
Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. J Physiol (2001) 2.10
Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem (1999) 2.09
Myonuclear domains in muscle adaptation and disease. Muscle Nerve (1999) 2.07
Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol (2001) 2.05
A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol (2007) 2.03
Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol (1989) 2.02
Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol (1985) (2007) 2.01
Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest (2004) 2.01
Postexercise net protein synthesis in human muscle from orally administered amino acids. Am J Physiol (1999) 2.00
Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J (2002) 1.99
Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol (1999) 1.95
Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J (2008) 1.93
Physiology of a microgravity environment invited review: microgravity and skeletal muscle. J Appl Physiol (1985) (2000) 1.90
Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest (1997) 1.90
NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J (1999) 1.87
Control of the size of the human muscle mass. Annu Rev Physiol (2004) 1.83
Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett (2000) 1.82
Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) (2007) 1.80
Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem (2004) 1.75
Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J (2004) 1.75
Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res (2003) 1.72
Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol (1997) 1.71
Identification of a molecular signature of sarcopenia. Physiol Genomics (2005) 1.69
Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol (1999) 1.68
Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol (2006) 1.63
Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol (1985) (1998) 1.59
Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol (2003) 1.59
Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol (2002) 1.58
Functional genomics identifies TOR-regulated genes that control growth and division. Curr Biol (2006) 1.57
Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle. J Physiol (2005) 1.57
Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology (2008) 1.54
Id2 expression during apoptosis and satellite cell activation in unloaded and loaded quail skeletal muscles. Am J Physiol Regul Integr Comp Physiol (2002) 1.53
Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J (1996) 1.52
Human single muscle fibre function with 84 day bed-rest and resistance exercise. J Physiol (2004) 1.52
Effects of supplement timing and resistance exercise on skeletal muscle hypertrophy. Med Sci Sports Exerc (2006) 1.51
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology (2006) 1.49
A 1.3 kb promoter fragment confers spatial and temporal expression of utrophin A mRNA in mouse skeletal muscle fibers. Neuromuscul Disord (2005) 1.45
The RNA-binding protein HuD: a regulator of neuronal differentiation, maintenance and plasticity. Bioessays (2006) 1.33
Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends Mol Med (2006) 1.23
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet (2003) 1.23
Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP. Mol Ther (2004) 1.21
Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling. Proc Natl Acad Sci U S A (2003) 1.20
BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci (2006) 1.16
The utrophin A 5'-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers. J Biol Chem (2005) 1.15
Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum Mol Genet (2011) 1.12
The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing. J Cell Biol (2012) 1.09
Brain-derived neurotrophic factor regulates satellite cell differentiation and skeltal muscle regeneration. Mol Biol Cell (2010) 1.06
Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J (2005) 1.05
Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway. FASEB J (2004) 1.05
Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling. Nucleic Acids Res (2007) 1.05
Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Hum Mol Genet (2009) 1.04
Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. J Neurochem (2011) 1.01
Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Hum Mol Genet (2006) 0.99
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction. Am J Physiol Cell Physiol (2005) 0.98
Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression. EMBO Rep (2002) 0.95
IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells. PLoS One (2008) 0.94
Localization of the RNA-binding proteins Staufen1 and Staufen2 at the mammalian neuromuscular junction. J Neurochem (2003) 0.94
The KATP channel Kir6.2 subunit content is higher in glycolytic than oxidative skeletal muscle fibers. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Localizing synaptic mRNAs at the neuromuscular junction: it takes more than transcription. Bioessays (2003) 0.91
p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton. Am J Physiol Renal Physiol (2003) 0.91
BDNF rescues myosin heavy chain IIB muscle fibers after neonatal nerve injury. Am J Physiol Cell Physiol (2004) 0.91
Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA (2013) 0.90
The RNA-binding protein HuR binds to acetylcholinesterase transcripts and regulates their expression in differentiating skeletal muscle cells. J Biol Chem (2005) 0.86
Ca2+/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression. Appl Physiol Nutr Metab (2007) 0.86
Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle. Mol Biol Cell (2007) 0.85
Post-transcriptional regulation of acetylcholinesterase mRNAs in nerve growth factor-treated PC12 cells by the RNA-binding protein HuD. J Biol Chem (2002) 0.85
KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity. Am J Physiol Endocrinol Metab (2007) 0.85
Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells. Hum Gene Ther (2004) 0.84
The RNA-binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy. J Neurosci (2007) 0.83
Trans-acting factors governing acetylcholinesterase mRNA metabolism in neurons. Front Mol Neurosci (2012) 0.83
Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle. Nucleic Acids Res (2013) 0.81
The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets. FASEB J (2013) 0.81
Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics. Hum Mol Genet (2013) 0.81
AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy. Trends Mol Med (2013) 0.81
Impaired fast axonal transport in neurons of the sciatic nerves from dystonia musculorum mice. J Neurochem (2003) 0.81
Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle. Am J Physiol Cell Physiol (2011) 0.80
Role of ELAV-like RNA-binding proteins HuD and HuR in the post-transcriptional regulation of acetylcholinesterase in neurons and skeletal muscle cells. Chem Biol Interact (2005) 0.79
Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells. Am J Physiol Renal Physiol (2010) 0.79
Characterization of multiple exon 1 variants in mammalian HuD mRNA and neuron-specific transcriptional control via neurogenin 2. J Neurosci (2012) 0.78
Troglitazone induces extracellular matrix and cytoskeleton remodeling in mouse collecting duct cells. J Biomed Biotechnol (2012) 0.77